Insiders Helix BioPharma Corp.

Equities

HBP

CA4229101098

Market Closed - Toronto S.E. Other stock markets 01:21:13 15/05/2024 am IST			5-day change	1st Jan Change
0.21 ^CAD	-8.70%		-8.70%	0.00%

08/04	Helix BioPharma Corp. announced that it has received CAD 1.915 million in funding	CI
28/03	Helix BioPharma Corp. announced that it expects to receive CAD 1.915 million in funding	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Helix BioPharma Corp. Appoints Praveen Varshney as Corporate Secretary	14/02	CI
Helix BioPharma Corp. Appoints Praveen Varshney as Chief Financial Officer	14/02	CI
Helix Biopharma Corp. Announces Board Changes	22/23/22	CI
Helix BioPharma Corp. Announces Executive Changes	22/23/22	CI
Helix BioPharma Corp. Announces Board Changes	09/22/09	CI
Helix BioPharma Corp. Announces CEO Changes	09/22/09	CI
Helix BioPharma Corp. Appoints Frank Gary Renshaw as Chief Medical Officer	04/22/04	CI
Helix BioPharma Corp. Appoints Gabrielle M Siegers as Head of Research Development Based Out of its Lab in Edmonton	02/22/02	CI
Helix BioPharma Corp. Appoints Namrata Malhotra as Corporate Secretary	18/22/18	CI
Helix BioPharma Corp. Appoints Hatem Kawar as Chief Financial Officer	18/22/18	CI
Helix BioPharma Appoints Gabor as Permanent Chief Executive	18/22/18	MT
Helix Biopharma Corp. Appoints Artur Gabor as Chief Executive Officer	18/22/18	CI
Helix Biopharma Corp. Announces Board Changes	18/22/18	CI
Helix Biopharma Corp. Announces Resignation of Krzysztof Saczek from the Board of Directors	07/22/07	CI
Helix BioPharma Corp. Announces Resignation of Frank Michalargias as Chief Financial Officer	23/22/23	CI
Helix Biopharma Corp. Announces Resignation of Adam Uszpolewicz as Director	23/22/23	CI
Helix BioPharma Corp. Announces Demise of S Slawomir Majewski, Interim Chief Executive Officer	16/22/16	CI
Helix BioPharma Corp. Announces Demise of Chairman of the Board of Director S Slawomir Majewski	16/22/16	CI
Helix BioPharma Corp. Appoints Adam Uszpolewicz to its Board of Directors	29/22/29	CI
Helix BioPharma Corp Appoints Slawomir Majewski as Interim CEO	21/21/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Helix BioPharma Corp.

Equities

HBP

CA4229101098

Insiders

Filters